Page 13 - Humacyte Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Humacyte board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Humacyte Board Today - Breaking & Trending Today

Humacyte (NASDAQ:HUMA) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Humacyte (NASDAQ:HUMA – Get Rating) announced its quarterly earnings data on Friday. The company reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.02, MarketWatch Earnings reports. NASDAQ:HUMA opened at $5.37 on Monday. The stock’s fifty day moving average price is $6.60 and its two-hundred day moving average price […] ....

United States , Piper Sandler , Penserra Capital Management , Zacks Investment Research , America Corp , Humacyte Inc , Charles Schwab Investment Management Inc , Advisor Group Holdings Inc , Citigroup Inc , Get Rating , Marketwatch Earnings , Capital Management , Group Holdings , Schwab Investment Management , Investment Research , Nasdaq Huma ,

Financial Contrast: Humacyte (NASDAQ:HUMA) and Cullinan Oncology (NASDAQ:CGEM)

Humacyte (NASDAQ:HUMA – Get Rating) and Cullinan Oncology (NASDAQ:CGEM – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk. Profitability This table compares Humacyte and Cullinan Oncology’s net margins, […] ....

New York , United States , United Kingdom , Humacyte Company Profile Get Rating , Cullinan Pearl Corp , Cullinan Oncology Company Profile Get Rating , Alpha Healthcare Acquisition Corp , Cullinan Oncology Inc , Get Rating , Cullinan Oncology , Given Cullinan Oncology , Company Profile , Healthcare Acquisition , Oncology Company Profile , Oncology Inc , Cullinan Pearl , Nasdaq Huma , Stock Comparison , Stock Analysis ,

Humacyte (NASDAQ:HUMA) Issues Quarterly Earnings Results

Humacyte (NASDAQ:HUMA – Get Rating) issued its quarterly earnings results on Tuesday. The company reported $0.41 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.20) by $0.61, MarketWatch Earnings reports. NASDAQ:HUMA opened at $7.06 on Friday. The business has a 50 day moving average price of $5.76 and a […] ....

New York , United States , Thomson Reuter , Piper Sandler , Penserra Capital Management , Zacks Investment Research , Renaissance Technologies , America Corp , Jpmorgan Chase Co , Alpha Healthcare Acquisition Corp , Group Plc , Get Rating , Marketwatch Earnings , Capital Management , General Group Plc , Healthcare Acquisition , Nasdaq Huma ,

Piper Sandler Lowers Humacyte (NASDAQ:HUMA) Price Target to $10.00

Humacyte (NASDAQ:HUMA – Get Rating) had its target price decreased by equities researchers at Piper Sandler from $17.00 to $10.00 in a research note issued on Tuesday, The Fly reports. Piper Sandler’s price target suggests a potential upside of 37.55% from the stock’s previous close. Separately, Zacks Investment Research upgraded Humacyte from a “hold” rating […] ....

New York , United States , Piper Sandler , Penserra Capital Management , Goldman Sachs Group Inc , Virtu Financial , Zacks Investment Research , Alpha Healthcare Acquisition Corp , Blackrock Inc , Get Rating , Sachs Group , State Teachers Retirement System , Healthcare Acquisition , Nasdaq Huma , Lower Price Target ,

Analysts Anticipate Humacyte, Inc. (NASDAQ:HUMA) to Announce -$0.19 Earnings Per Share

Wall Street analysts expect Humacyte, Inc. (NASDAQ:HUMA – Get Rating) to announce ($0.19) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Humacyte’s earnings. The firm is expected to issue its next earnings results before the market opens on Monday, January 1st. On average, analysts expect […] ....

New York , United States , Humacyte Company Profile Get Rating , Penserra Capital Management , Zacks Investment Research , America Corp , Humacyte Inc , United Asset Strategies Inc , Alpha Healthcare Acquisition Corp , Citigroup Inc , Wall Street , Get Rating , Capital Management , Retirement System , United Asset Strategies , Company Profile , Healthcare Acquisition , Nasdaq Huma ,